Literature DB >> 15212162

Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney.

Yumiko Urakami1, Naoko Kimura, Masahiro Okuda, Ken-ichi Inui.   

Abstract

PURPOSE: Creatinine is excreted into urine by tubular secretion in addition to glomerular filtration. The purpose of this study was to clarify molecular mechanisms underlying the tubular secretion of creatinine in the human kidney.
METHODS: Transport of [14C]creatinine by human organic ion transporters (SLC22A) was assessed by HEK293 cells expressing hOCT1, hOCT2, hOCT2-A, hOAT1, and hOAT3.
RESULTS: Among the organic ion transporters examined, only hOCT2 stimulated creatinine uptake when expressed in HEK293 cells. Creatinine uptake by hOCT2 was dependent on the membrane potential. The Michaelis constant (Km) for creatinine transport by hOCT2 was 4.0 mM, suggesting low affinity. Various cationic drugs including cimetidine and trimethoprim, but not anionic drugs, markedly inhibited creatinine uptake by hOCT2.
CONCLUSION: These results suggest that hOCT2, but not hOCT1, is responsible for the basolateral membrane transport of creatinine in the human kidney.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212162     DOI: 10.1023/b:pham.0000029286.45788.ad

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  34 in total

1.  ENDOGENOUS-CREATININE CLEARANCE AND GLOMERULAR-FILTRATION RATE.

Authors:  G M BERLYNE; H VARLEY; S NILWARANGKUR; M HOERNI
Journal:  Lancet       Date:  1964-10-24       Impact factor: 79.321

2.  THE RENAL EXCRETION OF ENDOGENOUS CREATININE IN MAN. COMPARISON WITH EXOGENOUS CREATININE AND INULIN.

Authors:  B F Miller; A W Winkler
Journal:  J Clin Invest       Date:  1938-01       Impact factor: 14.808

3.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney.

Authors:  Hideyuki Motohashi; Yuji Sakurai; Hideyuki Saito; Satohiro Masuda; Yumiko Urakami; Maki Goto; Atsushi Fukatsu; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

4.  Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1.

Authors:  A E Busch; S Quester; J C Ulzheimer; V Gorboulev; A Akhoundova; S Waldegger; F Lang; H Koepsell
Journal:  FEBS Lett       Date:  1996-10-21       Impact factor: 4.124

Review 5.  Mechanisms mediating renal secretion of organic anions and cations.

Authors:  J B Pritchard; D S Miller
Journal:  Physiol Rev       Date:  1993-10       Impact factor: 37.312

6.  Inhibition of renal creatinine secretion by cimetidine in humans.

Authors:  E Burgess; A Blair; K Krichman; R E Cutler
Journal:  Ren Physiol       Date:  1982

7.  Cloning and characterization of two human polyspecific organic cation transporters.

Authors:  V Gorboulev; J C Ulzheimer; A Akhoundova; I Ulzheimer-Teuber; U Karbach; S Quester; C Baumann; F Lang; A E Busch; H Koepsell
Journal:  DNA Cell Biol       Date:  1997-07       Impact factor: 3.311

8.  Ranitidine has no influence on tubular creatinine secretion.

Authors:  J G van den Berg; M G Koopman; L Arisz
Journal:  Nephron       Date:  1996       Impact factor: 2.847

9.  Apparent reduction of endogenous creatinine clearance by salicylate treatment.

Authors:  H C Burry; P A Dieppe
Journal:  Br Med J       Date:  1976-07-03

10.  Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.

Authors:  Y Urakami; M Okuda; S Masuda; H Saito; K I Inui
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

View more
  52 in total

1.  Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.

Authors:  Fei Li; Andrew D Patterson; Kristopher W Krausz; Naoki Tanaka; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

2.  Reversible elevations of serum creatinine levels but no effect on glomerular filtration during treatment with the direct thrombin inhibitor AZD0837.

Authors:  Kajs-Marie Schützer; Maria K Svensson; Sofia Zetterstrand; Ulf G Eriksson; Karin Wåhlander
Journal:  Eur J Clin Pharmacol       Date:  2010-06-10       Impact factor: 2.953

3.  Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine.

Authors:  Fabian Müller; Jörg König; Hartmut Glaeser; Ingrid Schmidt; Oliver Zolk; Martin F Fromm; Renke Maas
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

4.  Lack of effect of DX-619, a novel des-fluoro(6)-quinolone, on glomerular filtration rate measured by serum clearance of cold iohexol.

Authors:  Nenad Sarapa; Prachi Wickremasingha; Nanxiang Ge; Richard Weitzman; Merynda Fuellhart; Cindy Yen; Julia Lloyd-Parks
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

Review 5.  The interplay between drugs and the kidney in premature neonates.

Authors:  Michiel F Schreuder; Ruud R G Bueters; Karel Allegaert
Journal:  Pediatr Nephrol       Date:  2013-11-12       Impact factor: 3.714

Review 6.  Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.

Authors:  Hideyuki Motohashi; Ken-ichi Inui
Journal:  AAPS J       Date:  2013-02-22       Impact factor: 4.009

7.  Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity.

Authors:  Dong Guo; Hong Yang; Qing Li; Hyo Jung Bae; Obinna Obianom; Sujuan Zeng; Tong Su; James E Polli; Yan Shu
Journal:  Pharm Res       Date:  2018-09-06       Impact factor: 4.200

8.  Impact of urine concentration adjustment method on associations between urine metals and estimated glomerular filtration rates (eGFR) in adolescents.

Authors:  Virginia M Weaver; Gonzalo García Vargas; Ellen K Silbergeld; Stephen J Rothenberg; Jeffrey J Fadrowski; Marisela Rubio-Andrade; Patrick J Parsons; Amy J Steuerwald; Ana Navas-Acien; Eliseo Guallar
Journal:  Environ Res       Date:  2014-05-08       Impact factor: 6.498

9.  A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects.

Authors:  Justin Koteff; Julie Borland; Shuguang Chen; Ivy Song; Amanda Peppercorn; Takaaki Koshiba; Courtney Cannon; Heather Muster; Stephen C Piscitelli
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

Review 10.  The renal effects of ALK inhibitors.

Authors:  Hassan Izzedine; Rania Kheder El-Fekih; Mark A Perazella
Journal:  Invest New Drugs       Date:  2016-07-29       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.